Literature DB >> 1674600

Pathophysiology of cytotoxic drug-induced emesis: far from crystal-clear.

C Seynaeve1, P H De Mulder, J Verweij.   

Abstract

Both radiotherapy and chemotherapy for cancer are capable of causing severe nausea and vomiting, which formerly often interfered with the patient's compliance to treatment. The basic pathway and pharmacological mechanisms involved in this are still poorly understood. The recent discovery, however, that 5-HT3 receptor antagonists can prevent or greatly reduce chemotherapy-induced emesis led to a re-evaluation of the sequence of events occurring in the protective emetic reflex, which are reviewed in this paper. The vomiting centre co-ordinates the incoming and outgoing information, and is thought to be represented by complex interactions between different adjacent areas in the brainstem. Whether the main role in the emetic reflex arch is accomplished by either the central part (chemoreceptor trigger zone) or the peripheral part (gastro-intestinal tract) needs further confirmation A more important role, however, of the vagal nerve and the gastro-intestinal tract is generally accepted. The neurotransmitter serotonin (5-HT) appears to play a major role in chemotherapy-induced emesis via the 5-HT receptor. These indications could form the basis for further investigations into the involvement of other neurotransmitters, and the character of their interactions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1674600     DOI: 10.1007/bf01963876

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  33 in total

1.  Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.

Authors:  B Costall; A M Domeney; R J Naylor; M B Tyers
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

2.  Antiemetics: neurotransmitter receptor binding predicts therapeutic actions.

Authors:  S J Peroutka; S H Snyder
Journal:  Lancet       Date:  1982-03-20       Impact factor: 79.321

3.  Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting.

Authors:  L X Cubeddu; I S Hoffmann; N T Fuenmayor; A L Finn
Journal:  N Engl J Med       Date:  1990-03-22       Impact factor: 91.245

4.  The structure of the mammalian area postrema.

Authors:  K R Brizzee; P M Klara
Journal:  Fed Proc       Date:  1984-12

5.  Cisplatin-induced vomiting eliminated by ablation of the area postrema in cats.

Authors:  L E McCarthy; H L Borison
Journal:  Cancer Treat Rep       Date:  1984-02

6.  Role of the area postrema in vomiting and related functions.

Authors:  H L Borison; R Borison; L E McCarthy
Journal:  Fed Proc       Date:  1984-12

7.  Chemotherapeutic agents do not interact with neurotransmitter receptors.

Authors:  S J Peroutka
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 8.  The neurophysiology of vomiting.

Authors:  P L Andrews; J Hawthorn
Journal:  Baillieres Clin Gastroenterol       Date:  1988-01

Review 9.  Recent advances in the management of nausea and vomiting caused by antineoplastic agents.

Authors:  K R Merrifield; B J Chaffee
Journal:  Clin Pharm       Date:  1989-03

Review 10.  Chemotherapy induced emesis--mechanisms and treatment: a review.

Authors:  C M Edwards
Journal:  J R Soc Med       Date:  1988-11       Impact factor: 18.000

View more
  2 in total

1.  Ruminal metabolism of leafy spurge in sheep and goats: A potential explanation for differential foraging on spurge by sheep, goats, and cattle.

Authors:  S L Kronberg; J W Walker
Journal:  J Chem Ecol       Date:  1993-09       Impact factor: 2.626

Review 2.  Treatment of chemotherapy-induced emesis in the 1990s: impact of the 5-HT3 receptor antagonists.

Authors:  P J Hesketh
Journal:  Support Care Cancer       Date:  1994-09       Impact factor: 3.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.